![Floris van Delft](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Floris van Delft is the founder of SynAffix BV, where he holds the title of Chief Scientific Officer since 2010.
He previously worked as an Associate Professor at Radboud University Nijmegen.
Dr. van Delft obtained a graduate and doctorate degree from the University of Leiden.
Floris van Delft active positions
| Companies | Position | Start |
|---|---|---|
SynAffix BV
 SynAffix BV BiotechnologyHealth Technology Develops antibody-drug conjugates | Founder | 01/01/2010 |
Former positions of Floris van Delft
| Companies | Position | End |
|---|---|---|
Radboud University Nijmegen
 Radboud University Nijmegen Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Training of Floris van Delft
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
5
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
University of Leiden
 University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Radboud University Nijmegen
Radboud University Nijmegen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SynAffix BV
SynAffix BV BiotechnologyHealth Technology Develops antibody-drug conjugates | Health Technology |
- Stock Market
- Insiders
- Floris van Delft
